Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247492567> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4247492567 endingPage "546" @default.
- W4247492567 startingPage "541" @default.
- W4247492567 abstract "The present report is the follow-up of patients enrolled in a phase II clinical trial using 125I-MAb 425 as an adjuvant treatment for high grade gliomas. Patient median survivals support published data from an earlier preliminary report. From January 29, 1987 to January 25, 1997, 180 patients diagnosed with astrocytoma with anaplastic foci (AAF) and glioblastoma multiforme (GBM) were treated as outpatients with an average of three weekly intravenous or intraarterial injections of radiolabeled MAb 425. The mean dose was 140 mCi (5.2 GBq). Only one patient who received a single dose of more than 60 mCi (2.2 GBq) experienced acute toxicity. Patients received prior surgery and radiation therapy, with and without chemotherapy. Overall median survival for patients with GBM and AAF was 13.4 and 50.9 months, respectively, with Karnofsky Performance Status (KPS) ranging from 40 to 100 and age ranging from 11 to 75 years. Prognostic factors (KPS and age) correlated positively with increased survival, with KPS the most important determinant of median survival. Data analysis was performed on patients followed 5 years or longer. We conclude that the administration of 125I-MAb 425 with intensive medical management demonstrates a significant increase in median survival and should be considered a therapeutic regimen for the management of patients with high grade gliomas." @default.
- W4247492567 created "2022-05-12" @default.
- W4247492567 creator A5003859653 @default.
- W4247492567 creator A5011894643 @default.
- W4247492567 creator A5019956173 @default.
- W4247492567 creator A5022204564 @default.
- W4247492567 creator A5025801354 @default.
- W4247492567 creator A5047513658 @default.
- W4247492567 creator A5053401288 @default.
- W4247492567 date "2002-12-01" @default.
- W4247492567 modified "2023-10-18" @default.
- W4247492567 title "Radioiodinated (I-125) Monoclonal Antibody 425 in the Treatment of High Grade Glioma Patients" @default.
- W4247492567 doi "https://doi.org/10.1097/01.coc.0000041009.06780.e5" @default.
- W4247492567 hasPublicationYear "2002" @default.
- W4247492567 type Work @default.
- W4247492567 citedByCount "21" @default.
- W4247492567 countsByYear W42474925672012 @default.
- W4247492567 countsByYear W42474925672016 @default.
- W4247492567 countsByYear W42474925672018 @default.
- W4247492567 countsByYear W42474925672019 @default.
- W4247492567 countsByYear W42474925672020 @default.
- W4247492567 countsByYear W42474925672021 @default.
- W4247492567 countsByYear W42474925672022 @default.
- W4247492567 countsByYear W42474925672023 @default.
- W4247492567 crossrefType "journal-article" @default.
- W4247492567 hasAuthorship W4247492567A5003859653 @default.
- W4247492567 hasAuthorship W4247492567A5011894643 @default.
- W4247492567 hasAuthorship W4247492567A5019956173 @default.
- W4247492567 hasAuthorship W4247492567A5022204564 @default.
- W4247492567 hasAuthorship W4247492567A5025801354 @default.
- W4247492567 hasAuthorship W4247492567A5047513658 @default.
- W4247492567 hasAuthorship W4247492567A5053401288 @default.
- W4247492567 hasConcept C126322002 @default.
- W4247492567 hasConcept C141071460 @default.
- W4247492567 hasConcept C2776694085 @default.
- W4247492567 hasConcept C2778227246 @default.
- W4247492567 hasConcept C2778880634 @default.
- W4247492567 hasConcept C2779083369 @default.
- W4247492567 hasConcept C2781413609 @default.
- W4247492567 hasConcept C502942594 @default.
- W4247492567 hasConcept C509974204 @default.
- W4247492567 hasConcept C71924100 @default.
- W4247492567 hasConcept C90924648 @default.
- W4247492567 hasConceptScore W4247492567C126322002 @default.
- W4247492567 hasConceptScore W4247492567C141071460 @default.
- W4247492567 hasConceptScore W4247492567C2776694085 @default.
- W4247492567 hasConceptScore W4247492567C2778227246 @default.
- W4247492567 hasConceptScore W4247492567C2778880634 @default.
- W4247492567 hasConceptScore W4247492567C2779083369 @default.
- W4247492567 hasConceptScore W4247492567C2781413609 @default.
- W4247492567 hasConceptScore W4247492567C502942594 @default.
- W4247492567 hasConceptScore W4247492567C509974204 @default.
- W4247492567 hasConceptScore W4247492567C71924100 @default.
- W4247492567 hasConceptScore W4247492567C90924648 @default.
- W4247492567 hasIssue "6" @default.
- W4247492567 hasLocation W42474925671 @default.
- W4247492567 hasOpenAccess W4247492567 @default.
- W4247492567 hasPrimaryLocation W42474925671 @default.
- W4247492567 hasRelatedWork W1523171941 @default.
- W4247492567 hasRelatedWork W165245056 @default.
- W4247492567 hasRelatedWork W1982280388 @default.
- W4247492567 hasRelatedWork W2132757537 @default.
- W4247492567 hasRelatedWork W2158789712 @default.
- W4247492567 hasRelatedWork W2359108547 @default.
- W4247492567 hasRelatedWork W2390880754 @default.
- W4247492567 hasRelatedWork W2460377520 @default.
- W4247492567 hasRelatedWork W2808624194 @default.
- W4247492567 hasRelatedWork W59994307 @default.
- W4247492567 hasVolume "25" @default.
- W4247492567 isParatext "false" @default.
- W4247492567 isRetracted "false" @default.
- W4247492567 workType "article" @default.